Protagonist Therapeutics Inc — キャッシュフロー (NASDAQ:PTGX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -72.48 M-107.86 M-108.14 M-70.24 M184.15 M57.67 M 57.67 M 投資活動によるキャッシュフロー -90.97 M-15.86 M91.47 M-39.26 M-299.48 M-49.33 M -49.33 M 財務活動によるキャッシュフロー 247.63 M129.92 M18.84 M170.48 M25.85 M22.86 M 22.86 M フリーキャッシュフロー -72.95 M-108.97 M-108.93 M-70.84 M182.8 M56.08 M 56.08 M

ニュース

J&J raises guidance for 2026 on strong start to the year

Growth vs. Stability: Lilly and J&J's 2026 Investment Face-Off

Can New Drugs Drive J&J's Innovative Medicine Despite Stelara LOE?

J&J's Pipeline Surge Sets Up Stronger Growth From New Drugs in 2026

J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?

Protagonist Partners With JNJ To Compete With AbbVie's Skyrizi (PTGX)

Protagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's Why

Protagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?

J&J Expands New Drug Portfolio With Icotyde's FDA Approval

Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment Transcript

プロタゴニスト・セラピューティクス株が98.65ドルで史上最高値を更新

Protagonist Therapeutics stock hits all-time high at 98.65 USD